Saba Capital Management, L.P. filed a Form 4 on November 2, 2026, disclosing a purchase of common stock in Gabelli Healthcare & WellnessRx Trust on October 30, 2026.

Key Highlights

  • Transaction date: October 30, 2026, with 10,196 shares of common stock acquired.
  • Purchase price: $10.13 per share, coded as a open-market purchase (transaction code P).
  • Beneficial ownership following transaction: 2,184,821 shares held indirectly.
  • Ownership structure: Securities are held by funds and/or accounts for which Saba Capital Management, L.P. serves as investment manager.
  • General partner link: Boaz R. Weinstein serves as managing member of Saba Capital Management GP, LLC, the general partner of Saba Capital Management, L.P.
  • Reporting person status: Saba Capital Management, L.P. is identified as a 10% owner of the issuer.

Saba Capital Management's October 30 Purchase in Gabelli Healthcare & WellnessRx Trust

According to the Form 4 filed with the U.S. Securities and Exchange Commission on November 2, 2026, Saba Capital Management, L.P. reported the acquisition of 10,196 shares of common stock in Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) at a price of $10.13 per share. The transaction was dated October 30, 2026, and was coded as a purchase (code P) under the SEC's transaction coding system.

The filing indicates that following this transaction, Saba Capital Management, L.P. beneficially owns 2,184,821 shares indirectly. As the filing explains in its response footnote, "The securities reported herein are held by funds and/or accounts for which Saba Capital Management, L.P. serves as investment manager." The filing further notes that Boaz R. Weinstein serves as the managing member of Saba Capital Management GP, LLC, the general partner of Saba Capital Management, L.P. No derivative securities transactions were reported.

Saba Capital Management, L.P. is identified in the filing as a 10% owner of Gabelli Healthcare & WellnessRx Trust. The form was signed on November 2, 2026, by Maria Piccolino on behalf of Saba Capital Management, L.P., and separately acknowledged by Boaz Weinstein on the same date.

What Was Disclosed

Saba Capital Management, L.P. disclosed a purchase of 10,196 common shares of Gabelli Healthcare & WellnessRx Trust at $10.13 per share on October 30, 2026, bringing its total indirect beneficial ownership to 2,184,821 shares, according to the Form 4 filed November 2, 2026.